Legend Biotech Corporation (LEGN) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 305.1M | 306.38M | 272.33M | 255.06M | 195.05M | 186.52M | 160.21M | 186.52M | 93.99M | 79.46M | 96.01M | 73.33M |
| Revenue Growth % | 56.42% | 64.26% | 69.99% | 36.74% | 107.52% | 134.73% | 66.86% | 154.36% | 158.67% | 187.57% | 250.91% | 512.56% |
| Cost of Goods Sold | 175.9M | 123.46M | 115.31M | 97.99M | 71.34M | 73.92M | 55.47M | 50.45M | 54.74M | 32.45M | 48.65M | 128.46M |
| COGS % of Revenue | 57.65% | 40.3% | 42.34% | 38.42% | 36.58% | 39.63% | 34.62% | 27.05% | 58.24% | 40.84% | 50.67% | 175.18% |
| Gross Profit | 129.2M | 182.92M | 157.02M | 157.07M | 123.71M | 112.6M | 104.74M | 136.07M | 39.25M | 47.01M | 47.36M | -55.13M |
| Gross Margin % | 42.35% | 59.7% | 57.66% | 61.58% | 63.42% | 60.37% | 65.38% | 72.95% | 41.76% | 59.16% | 49.33% | -75.18% |
| Gross Profit Growth % | 4.44% | 62.45% | 49.92% | 15.43% | 215.17% | 139.5% | 121.13% | 346.81% | 5329.05% | 8205.88% | 146.16% | -1009.76% |
| Operating Expenses | 179M | 203.52M | 200.48M | 178.95M | 174.36M | 187M | 174.79M | 178.04M | 157.12M | 166.86M | 139.89M | 144.97M |
| OpEx % of Revenue | 58.67% | 66.43% | 73.62% | 70.16% | 89.39% | 100.25% | 109.1% | 95.45% | 167.16% | 209.99% | 145.69% | 197.7% |
| Selling, General & Admin | 90.1M | 101.19M | 87.33M | 80.65M | 72.43M | 83.13M | 79.57M | 65.42M | 56.15M | 62.38M | 44.03M | 49.18M |
| SG&A % of Revenue | 29.53% | 33.03% | 32.07% | 31.62% | 37.13% | 44.57% | 49.67% | 35.07% | 59.74% | 78.51% | 45.86% | 67.07% |
| Research & Development | 85.96M | 101.33M | 113.15M | 98.3M | 101.92M | 104.43M | 95.52M | 112.63M | 100.96M | 105.68M | 95.86M | 95.79M |
| R&D % of Revenue | 28.17% | 33.07% | 41.55% | 38.54% | 52.25% | 55.99% | 59.62% | 60.38% | 107.42% | 132.99% | 99.84% | 130.63% |
| Other Operating Expenses | 1000K | 1000K | 0 | 0 | 0 | -563K | -306K | 0 | 0 | -1000K | 0 | 0 |
| Operating Income | -49.8M | -20.6M | -43.45M | -21.88M | -50.65M | -74.39M | -70.05M | -41.97M | -117.86M | -119.85M | -92.52M | -200.11M |
| Operating Margin % | -16.32% | -6.72% | -15.96% | -8.58% | -25.97% | -39.89% | -43.73% | -22.5% | -125.4% | -150.82% | -96.37% | -272.88% |
| Operating Income Growth % | 1.67% | 72.31% | 37.97% | 47.87% | 57.03% | 37.93% | 24.29% | 79.03% | 4.65% | 6.8% | 62.88% | -67.75% |
| EBITDA | -34.2M | -8.63M | -37.57M | -16.03M | -45.45M | -67.6M | -64.58M | -36.6M | -112.14M | -114.5M | -87.35M | -197.92M |
| EBITDA Margin % | -11.21% | -2.82% | -13.8% | -6.28% | -23.3% | -36.24% | -40.31% | -19.62% | -119.31% | -144.09% | -90.98% | -269.91% |
| EBITDA Growth % | 24.75% | 87.23% | 41.82% | 56.21% | 59.47% | 40.96% | 26.07% | 81.51% | 5.31% | 7.17% | 64.53% | -71.84% |
| D&A (Non-Cash Add-back) | 15.6M | 11.97M | 5.88M | 5.85M | 5.2M | 6.8M | 5.47M | 5.37M | 5.72M | 5.35M | 5.17M | 2.18M |
| EBIT | -47.6M | -14.12M | -39.07M | -119.58M | -94.07M | 45.66M | -115.38M | -12.49M | -54.31M | -140.99M | -56.82M | -104.31M |
| Net Interest Income | 1.8M | 2.47M | 4.03M | 5.23M | 7M | 8.5M | 11.13M | 11.56M | 8.39M | 11.48M | 12.74M | -5.18M |
| Interest Income | 7.3M | 7.95M | 9.67M | 10.47M | 12.06M | 13.65M | 16.63M | 17.05M | 13.87M | 17.3M | 18.42M | - |
| Interest Expense | 5.5M | 5.48M | 5.64M | 5.24M | 5.06M | 5.15M | 5.5M | 5.48M | 5.47M | 5.82M | 5.68M | 5.18M |
| Other Income/Expense | -3.3M | 1M | 4.38M | -102.92M | -48.48M | 114.91M | -50.84M | 24M | 58.08M | -26.96M | 30.03M | 1.27M |
| Pretax Income | -53.1M | -19.6M | -39.07M | -124.8M | -99.13M | 40.51M | -120.89M | -17.97M | -59.79M | -146.81M | -62.49M | -198.84M |
| Pretax Margin % | -17.4% | -6.4% | -14.35% | -48.93% | -50.82% | 21.72% | -75.46% | -9.63% | -63.61% | -184.75% | -65.09% | -271.16% |
| Income Tax | 1.2M | 11.22M | 616K | 582K | 1.79M | 14.23M | 4.43M | 226K | 5K | -1.99M | -288K | 290K |
| Effective Tax Rate % | -2.26% | -57.23% | -1.58% | -0.47% | -1.8% | 35.12% | -3.67% | -1.26% | -0.01% | 1.36% | 0.46% | -0.15% |
| Net Income | -54.3M | -30.82M | -39.69M | -125.38M | -100.92M | 26.28M | -125.32M | -18.2M | -59.79M | -144.82M | -62.21M | -199.13M |
| Net Margin % | -17.8% | -10.06% | -14.57% | -49.16% | -51.74% | 14.09% | -78.23% | -9.76% | -63.62% | -182.24% | -64.79% | -271.55% |
| Net Income Growth % | 46.19% | -217.24% | 68.33% | -589.05% | -68.78% | 118.15% | -101.46% | 90.86% | 46.66% | -6.58% | 26.78% | -3.05% |
| Net Income (Continuing) | -54.3M | -30.82M | -39.69M | -125.38M | -100.92M | 26.28M | -125.32M | -18.2M | -59.79M | -144.82M | -62.21M | -199.13M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.30 | -0.17 | -0.22 | -0.68 | -0.55 | 0.14 | -0.68 | -0.10 | -0.33 | -0.80 | -0.34 | -1.14 |
| EPS Growth % | 45.45% | -221.43% | 67.65% | -582.73% | -66.67% | 117.5% | -100% | 91.26% | 51.47% | 5.88% | 37.04% | 8.8% |
| EPS (Basic) | -0.30 | -0.17 | -0.21 | -0.68 | -0.55 | 0.14 | -0.68 | -0.10 | -0.33 | -0.80 | -0.34 | -1.14 |
| Diluted Shares Outstanding | 184.73M | 184.73M | 184.64M | 184.14M | 183.76M | 182.85M | 182.73M | 182.6M | 182.01M | 181.91M | 181.79M | 175.26M |
| Basic Shares Outstanding | 184.73M | 184.73M | 180.41M | 184.14M | 183.76M | 182.85M | 182.73M | 182.6M | 182.01M | 181.91M | 181.79M | 175.26M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |